Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine Profiling in Different SARS-CoV-2 Genetic Variants
Zoia R. Korobova, N. A. Аrsentieva, N. E. Liubimova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14146-14146
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Comparative Study of Cytokine Profiles in SARS-CoV-2 Delta and Omicron Variants
Michaela Krivosova, Juliana Hanusrichterová, Vincent Lučanský, et al.
Bratislavské lekárske listy/Bratislava medical journal (2025)
Open Access | Times Cited: 1
Association between interleukin-10 gene polymorphisms (rs1800871, rs1800872, and rs1800896) and severity of infection in different SARS-CoV-2 variants
Sattar Jabbar Abbood Abbood, Enayat Anvari, Abolfazl Fateh
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 24
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants
Ralf Kircheis
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5451-5451
Open Access | Times Cited: 6
The Important Role of Interleukin-2 in COVID-19
Leila Ghanbari Naeini, Laleh Abbasi, Farzaneh Karimi, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 13
Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy
Estefanía Calvo‐Álvarez, Sarah D’Alessandro, Nunzia Zanotta, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies
Emily G. Oakes, Eilish Dillon, Katherine Buhler, et al.
Journal of Autoimmunity (2024) Vol. 148, pp. 103299-103299
Closed Access | Times Cited: 3
Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19
Zoia R. Korobova, N. A. Аrsentieva, Арег А. Тотолян
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13083-13083
Open Access | Times Cited: 6
Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France
Paul Laffont-Lozes, Didier Laureillard, Paul Loubet, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 88-88
Open Access | Times Cited: 4
Development and validation of a prognostic model based on immune variables to early predict severe cases of SARS-CoV-2 Omicron variant infection
Tianyu Lu, Qiuhong Man, Xueying Yu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Evaluation of febrile seizures in children infected with SARS-CoV-2 Omicron variant in Yunnan, China: a multi-center, retrospective observational study
Haifeng Liu, Rui Lü, Jian Yang, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 4
Insights into COVID‐19 pneumonia among older adults: Understanding aspiration and risk factors for mortality
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, et al.
Journal of the American Geriatrics Society (2024) Vol. 72, Iss. 8, pp. 2613-2614
Open Access | Times Cited: 1
Role of IL-27 in COVID-19: A Thin Line Between Protection and Disease Promotion
Zoia R. Korobova, N. A. Аrsentieva, Angela Santoni, et al.
(2024)
Open Access | Times Cited: 1
Dysregulated Inflammatory Cytokine Levels May Be Useful Markers in a Better Up-Dated Management of COVID-19
Marco Iuliano, Roberta Maria Mongiovì, Alberico Parente, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8890-8902
Open Access | Times Cited: 1
SARS-CoV-2 Genomic Variants and Their Relationship with the Expressional and Genomic Profile of Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2)
Henrique Borges da Silva Grisard, Marcos André Schörner, Fernando Hartmann Barazzetti, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2312-2312
Open Access | Times Cited: 1
Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes
Fiorenza Pennacchia, Eqrem Rusi, Wael Abu Ruqa, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 925-925
Open Access | Times Cited: 4
In-vitro studies of relative intracellular alterations caused by three variants of Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2)
Poorna Khaneja, Annette Angel, V. K. Joshi, et al.
Journal of Cellular Biotechnology (2024), pp. 1-6
Closed Access
Role of IL-27 in COVID-19: A Thin Line between Protection and Disease Promotion
Zoia R. Korobova, N. A. Аrsentieva, Angela Santoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7953-7953
Open Access
Laboratory blood markers in COVID-19 and their connection to Viral variant
Zoia R. Korobova, N. E. Liubimova, N. A. Аrsentieva, et al.
Russian Journal of Infection and Immunity (2024) Vol. 14, Iss. 3, pp. 429-436
Open Access
Association of SARS-CoV-2 Seropositivity with Persistent Immune Activation in HIV/Tuberculosis Co-Infected Patients
Ashwini Shete, Manisha Ghate, Hiroko Iwasaki, et al.
Reports — Medical Cases Images and Videos (2024) Vol. 7, Iss. 3, pp. 61-61
Open Access
Autoimmune disorders in patients with granulomatosis diseases after COVID-19: T- and B-cells subsets function
Анна Старшинова, I. V. Kudryavtsev, Artem Rubinstein, et al.
Russian Journal of Infection and Immunity (2024) Vol. 14, Iss. 2, pp. 251-266
Open Access
Immune and inflammation features of severe and critical Omicron infected patients during Omicron wave in China
Yongmei Liu, Guo Yaping, Haoting Zhan, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Alterations in the plasma proteome persist ten months after recovery from mild to moderate SARS-CoV-2 infection
J.A. Huapaya, Salina Gairhe, S.M. Kanth, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Epithelial Antimicrobial Peptide/Protein and Cytokine Expression Profiles Obtained from Nasopharyngeal Swabs of SARS-CoV-2-Infected and Non-Infected Subjects
Thilo Gambichler, Silke Goesmann, Marina Skrygan, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1471-1471
Open Access
Differential Responses of Lung and Intestinal Microbiota to SARS-CoV-2 Infection: A Comparative Study of the Wuhan and Omicron Strains in K18-hACE2 tg Mice
Chae Won Kim, Keun Bon Ku, Insu Hwang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Environmental exposures and familial background alter the induction of neuropathology and inflammation after SARS-CoV-2 infection.
Debotri Chatterjee, Drishya Kurup, Richard J. Smeyne
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top